SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-009589
Filing Date
2020-08-28
Accepted
2020-08-28 07:32:55
Documents
23
Period of Report
2020-08-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT cbmg_8k.htm 8-K 29324
2 ADDITIONAL EXHIBITS cbmg_ex991.htm EX-99.1 31394
3 ADDITIONAL EXHIBITS cbmg_ex992.htm EX-99.2 11346
4 IMAGE cbmg_ex991000.jpg GRAPHIC 44585
5 IMAGE cbmg_ex991001.jpg GRAPHIC 62332
6 IMAGE cbmg_ex991002.jpg GRAPHIC 38316
7 IMAGE cbmg_ex991003.jpg GRAPHIC 25581
8 IMAGE cbmg_ex991004.jpg GRAPHIC 45313
9 IMAGE cbmg_ex991005.jpg GRAPHIC 41307
10 IMAGE cbmg_ex991006.jpg GRAPHIC 35650
11 IMAGE cbmg_ex991007.jpg GRAPHIC 37323
12 IMAGE cbmg_ex991008.jpg GRAPHIC 35600
13 IMAGE cbmg_ex991009.jpg GRAPHIC 38983
14 IMAGE cbmg_ex991010.jpg GRAPHIC 46390
15 IMAGE cbmg_ex991011.jpg GRAPHIC 37753
16 IMAGE cbmg_ex991012.jpg GRAPHIC 36665
17 IMAGE cbmg_ex991013.jpg GRAPHIC 46758
18 IMAGE cbmg_ex991014.jpg GRAPHIC 48700
19 IMAGE cbmg_ex991015.jpg GRAPHIC 40153
20 IMAGE cbmg_ex991016.jpg GRAPHIC 43579
21 IMAGE cbmg_ex991017.jpg GRAPHIC 41801
22 IMAGE cbmg_ex991018.jpg GRAPHIC 34007
23 IMAGE cbmg_ex991019.jpg GRAPHIC 25320
  Complete submission text file 0001654954-20-009589.txt   1186350
Mailing Address 209 PERRY PARKWAY SUITE 13 GAITHERSBURG MD 20877
Business Address 209 PERRY PARKWAY SUITE 13 GAITHERSBURG MD 20877 (301) 825 5320
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36498 | Film No.: 201144884
SIC: 2836 Biological Products, (No Diagnostic Substances)